|
Volume 272, Number 12,
Issue of March 21, 1997
pp. 7899-7907
©1997 by The American Society for Biochemistry and Molecular Biology, Inc.
Submitochondrial Distribution of Three Key Steroidogenic Proteins
(Steroidogenic Acute Regulatory Protein and Cytochrome
P450scc and 3 -Hydroxysteroid Dehydrogenase Isomerase
Enzymes) upon Stimulation by Intracellular Calcium in Adrenal
Glomerulosa Cells*
(Received for publication, September 18, 1996, and in revised form, December 2, 1996)
Nadia
Cherradi
§,
Michel F.
Rossier
¶,
Michel B.
Vallotton
,
Rina
Timberg
,
Iddo
Friedberg
,
Joseph
Orly
,
Xing Jia
Wang
**,
Douglas M.
Stocco
** and
Alessandro M.
Capponi
From the Division of Endocrinology and Diabetology,
Department of Internal Medicine, Faculty of Medicine, University
Hospital, CH-1211 Geneva 14, Switzerland, the Department of
Biological Chemistry, Institute of Life Sciences, Hebrew University of
Jerusalem, Jerusalem 91904, Israel, and the ** Department of Cell
Biology and Biochemistry, Texas Tech University Health Sciences Center,
Lubbock, Texas 79430
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
FOOTNOTES
Acknowledgments
REFERENCES
ABSTRACT
In adrenal glomerulosa cells, angiotensin II (Ang
II) and potassium stimulate aldosterone synthesis through activation of the calcium messenger system. The rate-limiting step in steroidogenesis is the transfer of cholesterol to the inner mitochondrial membrane. This transfer is believed to depend upon the presence of the
steroidogenic acute regulatory (StAR) protein. The aim of this study
was 1) to examine the effect of changes in cytosolic free calcium
concentration and of Ang II on intramitochondrial cholesterol and 2) to
study the distribution of StAR protein in submitochondrial fractions during activation by Ca2+ and Ang II. To this end, freshly
prepared bovine zona glomerulosa cells were submitted to a high
cytosolic Ca2+ clamp (600 nM) or stimulated
with Ang II (10 nM) for 2 h. Mitochondria were
isolated and subfractionated into outer membranes, inner membranes
(IM), and contact sites (CS). Stimulation of intact cells with
Ca2+ or Ang II led to a marked, cycloheximide-sensitive
increase in cholesterol in CS (to 143 ± 3.2 and 151.1 ± 18.1% of controls, respectively) and in IM (to 119 ± 5.1 and
124.5 ± 6.5% of controls, respectively). Western blot analysis
revealed a cycloheximide-sensitive increase in StAR protein in
mitochondrial extracts of Ca2+-clamped glomerulosa cells
(to 159 ± 23% of controls). In submitochondrial fractions, there
was a selective accumulation of StAR protein in IM following
stimulation with Ca2+ (228 ± 50%). Similarly, Ang II
increased StAR protein in IM, and this effect was prevented by
cycloheximide. In contrast, neither Ca2+ nor Ang II had any
effect on the submitochondrial distribution of cytochrome
P450scc and 3 -hydroxysteroid dehydrogenase isomerase. The intramitochondrial presence of the latter enzyme was further confirmed by immunogold staining in rat adrenal fasciculata cells and
by immunoblot analysis in MA-10 mouse testicular Leydig cells. These
findings demonstrate that under acute stimulation with
Ca2+-mobilizing agents, newly synthesized StAR protein
accumulates in IM after transiting through CS. Moreover, our results
suggest that the import of StAR protein into IM may be associated with cholesterol transfer, thus promoting precursor supply to the two first
enzymes of the steroidogenic cascade within the mitochondria and
thereby activating mineralocorticoid synthesis.
INTRODUCTION
The Ca2+-mobilizing agonists angiotensin II (Ang
II)1 and K+ act as regulators
of aldosterone synthesis and secretion in adrenal glomerulosa cells.
The crucial role of the Ca2+ messenger in the acute
regulation of aldosterone production is firmly established (1-5).
Indeed, the steroidogenic response of isolated adrenal cells to Ang II
and K+ is highly dependent upon extracellular
Ca2+ concentration (6) and can be blocked by inhibitors of
Ca2+ influx across the plasma membrane (4). Moreover,
calmodulin antagonists have been shown to inhibit Ang II-stimulated
aldosterone production in zona glomerulosa cells (7).
Traditionally, aldosterone biosynthesis is functionally divided into
three consecutive phases. (i) In the early mitochondrial steps,
cholesterol is transported from intracellular lipid droplets into the
outer mitochondrial membrane (OM) and then to the inner mitochondrial
membrane (IM). The latter step represents the rate-limiting process in
all steroidogenic pathways (8) and is followed by the conversion of
cholesterol to pregnenolone by the cytochrome P450scc
enzyme. (ii) The intermediate steps take place on the endoplasmic
reticulum and involve the conversion of pregnenolone to progesterone by
3 -hydroxysteroid dehydrogenase isomerase and then to
11-deoxycorticosterone. (iii) The late steroidogenic steps are
localized back in the mitochondria and include the formation of
corticosterone and its conversion to aldosterone by cytochrome P45011 .
The regulation of intramitochondrial cholesterol transfer by
cAMP-dependent mechanisms has been extensively studied (9). While the transport of cholesterol from lipid droplets to the outer
mitochondrial membrane was found not to be affected by inhibitors of
protein synthesis in ACTH-stimulated adrenal cells, by contrast, the
subsequent delivery of cholesterol to the inner mitochondrial membrane
has been shown to be blocked by cycloheximide, with a concomitant
inhibition of steroid synthesis (10, 11). As a consequence, newly
synthesized "labile" proteins, among others, have been proposed to
be significant mediators of the acute steroidogenic response. In
primary adrenal cell cultures (12, 13) and in MA-10 mouse Leydig tumor
cells (14, 15), a family of 30-kDa mitochondrial phosphoproteins are
synthesized in response to stimulation with both trophic hormone and
cAMP analogs. These studies have demonstrated that the appearance and
the amounts of these proteins are highly correlated with the rate of
steroidogenesis. Recently, the steroidogenic acute regulatory (StAR)
protein has been identified, and its complementary DNA cloned (16-19).
A model has been proposed according to which cholesterol transfer from
the outer to the inner membrane might occur via intermembrane contact
sites (CS) during the import and proteolytic processing of the 37-kDa
precursor of StAR protein into mitochondria (18, 19). The most striking evidence for the essential role of StAR protein in the acute regulation of steroidogenesis was provided by studies of a lethal disease, lipoid
congenital adrenal hyperplasia, which manifests itself by a complete
inability of the newborn infant to synthesize steroids (20).
Mitochondria from affected adrenal glands and gonads fail to convert
cholesterol to pregnenolone, and as a consequence, cholesterol
accumulates within the cells. The defects responsible for this disease
are mutations in the StAR gene that generate truncated and
nonfunctional proteins (20). In addition to the first report on
StAR gene mutations causing lipoid congenital adrenal
hyperplasia (20), many additional examples of mutations in
StAR gene resulting in this disease are being reported
(21-23) and perhaps it is not as rare as previously thought. To date, mutations in the StAR gene are the only known causes of this
potentially lethal disease and, in a most dramatic manner, have
demonstrated the indispensable role of StAR protein in the production
of steroids.
Our laboratory has recently provided a direct demonstration of the
involvement of physiological rises in cytosolic free Ca2+
concentration ([Ca2+]i) in the activation of the
early steps of steroidogenesis, namely the stimulation of pregnenolone
synthesis in bovine adrenal glomerulosa cells (24). Both Ang II and
K+ elicit sustained changes in mitochondrial free calcium
concentration (25). However, the precise site(s) of action of
Ca2+ responsible for this increased pregnenolone formation
remained to be determined. We therefore undertook this work to
investigate the effect of rises in [Ca2+]i on the
intramitochondrial distribution of both cholesterol and StAR protein in
bovine adrenal glomerulosa cells. Our data show that physiological
rises in cytosolic Ca2+, produced either with a
Ca2+ inonophore or with Ang II, are indeed effective in
stimulating a specific StAR protein accumulation in the inner membranes
as well as a concomitant cholesterol transfer from the outer membranes to the contact sites and inner membranes, where P450scc and
3 -HSD are present to initiate the steroidogenic response.
EXPERIMENTAL PROCEDURES
Materials
Ionomycin was purchased from Calbiochem (Lucerne, Switzerland)
and [Ile5]Ang II from Bachem (Bubendorf, Switzerland).
Cholesterol oxidase, peroxidase, p-hydroxyphenylacetic acid,
aminoglutethimide, cycloheximide, and all other chemicals were
purchased from Sigma or from Fluka (Buchs, Switzerland). Antisera
against 3 -HSD and P450scc were kindly provided by Dr. G. Defaye (INSERM U244, CENG, Grenoble, France). The cytochrome
c oxidase antibody was an anti-bovine cytochrome
c oxidase subunit IV mouse monoclonal antibody supplied by
Molecular Probes, Inc. (Eugene, OR).
Bovine Adrenal Zona Glomerulosa Cell Preparation
Bovine adrenal glands were obtained from a local slaughterhouse.
Zona glomerulosa cells were prepared by enzymatic dispersion with
dispase and purified on Percoll density gradients as described in
detail (26). Purified glomerulosa cells were resuspended at a density
of 106 cells/ml in a modified Krebs-Ringer buffer (136 mM NaCl, 5 mM NaHCO3, 1.2 mM KH2PO4, 1.2 mM
MgSO4, 1.8 mM KCl, 1.2 mM
CaCl2, 5.5 mM D-glucose, and 20 mM Hepes, pH 7.4) and preincubated at 37 °C for 1 h
before being used in the subsequent experiments.
Calcium Clamping of Bovine Adrenal Glomerulosa Cells
After having been washed in Krebs-Ringer buffer, glomerulosa
cells were Ca2+-clamped as described (24), in the presence
of 2 µM ionomycin and 1 mM total
extracellular Ca2+, in order to achieve
[Ca2+]i = 600 nM (high
Ca2+ clamp). CHX was used at a final concentration of 1 mM. Control cells were Ca2+-clamped in
Krebs-Ringer buffer without Ca2+ in the presence of 0.2 mM EGTA (low Ca2+ clamp;
[Ca2+]i < 100 nM). Aminoglutethimide
(500 µM) was included in the incubation medium to inhibit
cholesterol side chain cleavage. At the end of a 2-h incubation period
at 37 °C, the cells were sedimented at 200 × g for
15 min. All subsequent operations were conducted at 4 °C in buffers
containing 500 µM aminoglutethimide.
Isolation of Mitochondria and Preparation of Submitochondrial
Fractions
Glomerulosa cells were homogenized with a Potter-Elvejhem
homogenizer (1200 rpm, 35 strokes) in 5 mM Tris-HCl buffer,
pH 7.4, containing 275 mM sucrose. The homogenate was
centrifuged at 200 × g for 15 min to remove large
debris and nuclei. Further centrifugation of the supernatant at
10,000 × g for 10 min yielded the mitochondria. The
mitochondrial pellet was washed twice at 8000 × g with
the same buffer.
We have previously shown that sucrose density gradient fractionation of
osmotically shocked adrenocortical mitochondria leads to the separation
of three distinct membrane populations containing specific marker
enzymes (27). Submitochondrial particles were prepared and separated by
sucrose density gradient (15-50%, density = 1.06-1.23)
centrifugation. Subsequently, the gradients were divided into 20 fractions of 500 µl that were assayed for marker enzyme activities.
Pooled fractions 4-7 (corresponding to the monoamine oxidase activity
peak; density = 1.08-1.11, specific to the outer mitochondrial
membranes), 9-11 (corresponding to the nucleoside-diphosphate kinase
activity peak; density = 1.13-1.15, specific to contact sites),
and 13-15 (corresponding to the cytochrome c oxidase
activity peak; density = 1.17-1.18, specific to the inner
mitochondrial membranes) from the original gradient were dialyzed
against 5 mM potassium phosphate buffer, pH 7.4, and stored
at 20 °C until use. Protein was quantified using the Bio-Rad protein microassay and bovine serum albumin as a standard.
For some experiments, mitoplasts and outer membranes were prepared as
follows. The washed mitochondria were exposed to a first swelling by
incubation in 20 mM sodium phosphate buffer, pH 7.4, for 20 min at 4 °C. Centrifugation at 10,000 × g yielded
the outer membranes (supernatant) and a pellet that was subjected to a
second swelling in the same buffer (15 min, 4 °C). Mitoplasts were
pelleted by centrifugation at 10,000 × g, washed, and
resuspended in 5 mM Tris-HCl and 250 mM sucrose
buffer (pH 7.4).
Marker Enzyme Assays
Cytochrome c oxidase (EC 1.9.3.1) and monoamine
oxidase (EC 1.4.3.4) activities were determined according to Appelmans et al. (28) and Otsuka and Kobayashi (29), respectively.
Nucleoside-diphosphate kinase (EC 2.7.4.6) was assayed as reported
previously (27), and NADPH-cytochrome c reductase (EC
1.6.99.3) activity was determined as described by Sottocasa et
al. (30).
Cholesterol Determination
The cholesterol content of submitochondrial fractions was
determined by a coupled cholesterol oxidase-peroxidase assay with cholesterol as a standard (31). Aliquots of the fractions (200 µl)
were transferred to glass tubes. To each sample were added 20 µl of
20 mM cholate and 1% Triton X-100 in 100 mM
potassium phosphate buffer, pH 7.4, followed by the addition of 25 µl
of 95% ethanol. The reaction mixture containing potassium phosphate buffer (100 mM), pH 7.4, cholesterol oxidase, peroxidase,
and p-hydroxyphenylacetic acid was then added to each
fraction in a final volume of 1 ml. Assay tubes were incubated for
1 h at 37 °C. Cholesterol oxidase generates
H2O2, and peroxidase catalyzes the reaction of
H2O2 with p-hydroxyphenylacetic acid
to yield a stable fluorescent product. The fluorescence was measured in a Jasco CAF-110 fluorometer (excitation, 325 nm; emission, 405 nm).
SDS-Polyacrylamide Gel Electrophoresis
SDS-polyacrylamide gel electrophoresis was performed according
to Laemmli (32). Mitochondrial proteins (5-25 µg/lane) were solubilized in sample buffer (60 mM Tris-HCl, pH 6.8, 2%
SDS, 5% -mercaptoethanol, 10% glycerol, and 0.01% bromphenol
blue) and loaded onto a 12% SDS-polyacrylamide minigel (Mini-Protean II system, Bio-Rad). Electrophoresis was performed at 150 V for 1 h.
Blotting Method and Immunodetection
SDS-polyacrylamide gel electrophoresis-resolved proteins were
electrophoretically transferred onto a nitrocellulose membrane (Schleicher & Schuell) according to Towbin et al. (33).
Following transfer, the membrane was incubated in blocking buffer
(phosphate-buffered saline containing 0.4% Tween 20 and 5% nonfat dry
milk) for 1 h at room temperature and then incubated either with
antibodies raised by one of us (17) against a peptide fragment (amino
acids 88-98) of the 30-kDa StAR protein or with antisera specific for the steroidogenic enzymes 3 -HSD and cytochrome P450scc
or for cytochrome c oxidase (1 h in phosphate-buffered
saline containing 0.4% Tween). The membrane was thoroughly washed with
the same buffer (3 × 10 min) and then incubated for 1 h with
horseradish peroxidase-labeled goat anti-rabbit IgG (Bio-Rad). The
nitrocellulose sheet was washed as described above, and the
antigen-antibody complex was revealed by enhanced chemiluminescence
using the Western blotting detection kit and Hyper-ECL film (Amersham,
Zürich, Switzerland). Quantitation of fluorograms was performed
using a Molecular Dynamics computing densitometer.
Electron Microscopy
Rat adrenal glands were removed, and small fragments were fixed
in 1% glutaraldehyde solution in phosphate-buffered saline for 1 h at room temperature (34). Preparation of the tissue blocks in LR
white resin (London Resin Co., Bassingstoke, United Kingdom) was
performed according to Newman et al. (35). Briefly, after
fixation, the tissue was washed in phosphate-buffered saline and
dehydrated in a graded series of up to 70% ethanol. The non-osmicated fragments were infiltrated with LR white resin and then placed in
gelatin capsules for polymerization at 50 °C for 24 h (34). Thin sections were cut with a diamond knife and collected on nickel grids. Prior to incubation with antiserum, nonspecific antigenic sites
were blocked by incubation for 5 min at room temperature with normal
goat serum (1:100 dilution) in Tris-HCl/Tween buffer containing 0.9%
NaCl, 10 mM Tris-HCl, pH 8.2, and 0.1% Tween 20. The
sections were incubated overnight (4 °C) with antisera (1:20 dilution in Tris-HCl/Tween), followed by a 1-h incubation with a 1:10
dilution of 12-nm gold-labeled goat anti-rabbit IgG (Jackson ImmunoResearch Laboratories, Inc., West Grove, PA) in -TrisHCl/Tween. Finally, the sections were stained with 1% aqueous uranyl acetate and
lead citrate. The sections were observed and photographed using a
Philips 300 electron microscope. Cytochemical controls (data not shown)
included omission of the first antibody incubation step. Additional
controls included incubation of preimmune serum with the adrenal
sections (data not shown).
Analysis of Data
Results are expressed as means ± S.E. The mean values were
compared by analysis of variance using Fisher's test. A value of p < 0.05 was considered as statistically significant.
Image analysis of electron microscope micrographs was performed as
follows.
Acquisition
Low power electron microscope micrographs (see
Fig. 8, A and B) were scanned with a Vista-S8
scanner (UMAX Systems, Taipei, Taiwan) using a Power Macintosh 6100/60
computer (Apple Computer Corp.) at a resolution of 300 dpi and 256 gray-levels. Digitized images were analyzed on a Compaq Prosignia 300 PC using the IPWIN 1.3 software package (Media Cybernetics, Silver
Spring, MD).
Fig. 8.
Intramitochondrial localization of 3 -HSD
antigenic sites in rat adrenal gland. A, low power
micrograph depicting immunogold staining of 3 -HSD distribution in
giant mitochondria (m) and the endoplasmic reticulum
(ER). Note the lack of colloidal gold particles in the clear
lipid area (L) and intercellular spaces (ICS).
Arrows depict well preserved segments of the outer
mitochondrial membrane adjacent to the inner membrane.
Magnification × 34,125. B, a duplicate section as
shown in A immunostained with P450scc antiserum.
Note heavy mitochondrial (m) decoration with gold particles, in contrast to the very low level of antigen labeling in other intracellular compartments. Magnification × 27,125. C,
high power micrograph depicting a mitochondrion (m) wrapped
with multiple layers of smooth endoplasmic membranes
(arrows) heavily labeled with 3 -HSD antiserum.
L, coalesced lipid droplets. Magnification × 50,575. D, intramitochondrial localization of 3 -HSD. Note the decoration of immunoreactive 3 -HSD in the mitochondrion
intermembrane space proximal to the outer membrane (arrows).
The inset shows a higher magnification (×123,600) of the
boxed area in D, defining an additional four
categories by which the distribution of the gold particles can be
described (see Fig. 9): gold particles localized in the gray area
(thick arrows) of the matrix (M), membrane-bound gold particles facing the matrix (thin arrows),
membrane-bound particles (small arrowheads) facing the white
intermembrane spaces (IMS), and gold particles (large
arrowhead) localized in the midst of the inner membrane
space.
[View Larger Version of this Image (143K GIF file)]
Processing and Analysis
Regions of interest were marked
manually. Analysis of gold particle density was performed within
regions of interest that delineated appropriate organelles and areas of
interest within the cell. Pixel values within regions of interest were
modified using a -correction curve of 9.7. Images were then
subjected to a 5 × 5 horizontal edge detection filter. This
accentuated the particles while preserving a uniform background. Data
loss was negligible (data not shown). Segmentation of particles was performed using particle size, roundness, and gray-level criteria. After segmentation, particles were counted, and their density within
regions of interest was determined.
RESULTS
Characterization of the Submitochondrial Fractions of Bovine
Glomerulosa Cells
Fig. 1 illustrates the monoamine
oxidase, nucleoside-diphosphate kinase, and cytochrome c
oxidase activities measured in the pooled fractions of OM, CS, and IM
isolated from mitochondria of control cells (low Ca2+
clamp). As expected, the OM fraction contained the highest monoamine oxidase activity; the IM fraction was characterized by the highest cytochrome c oxidase activity; and CS displayed monoamine
oxidase and cytochrome c oxidase activities in addition to
nucleoside-diphosphate kinase activity. IM contained most of the
mitochondrial membrane proteins (57.9 ± 7.6% of the total,
n = 3), while CS and OM contained 36.3 ± 4.3 and
5.7 ± 1.7% of the total membrane proteins, respectively. Similar
profiles of mitochondrial membrane marker enzymes and protein content
were obtained following fractionation of mitochondria from high
Ca2+-clamped cells (data not shown).
Fig. 1.
Characterization of submitochondrial
membranes of bovine adrenal glomerulosa cells. Glomerulosa cells
were submitted for 2 h to a high Ca2+ clamp in the
presence of 500 µM aminoglutethimide as described under
"Experimental Procedures." Submitochondrial particles were isolated
by sucrose density gradient centrifugation as described under
"Experimental Procedures." The activities of mitochondrial marker
enzymes were determined in each fraction of the gradient (data not
shown). The fractions containing the peak of activity of each marker
enzyme were then pooled and used as OM, CS, and IM. These activities
are representative of four independent experiments. Ordinate
units are nmol of deaminated tryptamine/min/mg of protein for monoamine
oxidase (MAO), µmol of oxidized cytochrome
c/min/mg of protein for cytochrome c oxidase
(COX), and nmol of phosphorylated ADP/min/mg of protein for
nucleoside-diphosphate kinase (NDP-K).
[View Larger Version of this Image (23K GIF file)]
Calcium and Ang II Induce a CHX-sensitive Intramitochondrial
Cholesterol Transfer
We have previously shown in bovine adrenal
zona glomerulosa cells that the calcium ionophore ionomycin can be
effectively used at low concentration to clamp the cytosolic free
Ca2+ concentration at various physiological levels
(50-1000 nM) (24). These submicromolar
[Ca2+]i levels stimulate in a
concentration-dependent manner the early mitochondrial
steps of steroidogenesis as well as aldosterone synthesis (24).
To examine the effect of Ca2+ on intramitochondrial
cholesterol distribution, cholesterol content was determined in OM, CS, and IM from control (low Ca2+-clamped) cells and from high
Ca2+-clamped cells in the presence or absence of CHX. Fig.
2A shows that the stimulation of
ionomycin-treated glomerulosa cells with Ca2+ for 2 h
led to a marked decrease in cholesterol content in OM (to 65.2 ± 0.2% of controls, n = 4; p < 0.001),
with a concomitant increase in CS (to 143 ± 3.2% of controls;
p < 0.01) and a less pronounced but significant
augmentation in IM (to 119 ± 5.1% of controls; p < 0.05).
Fig. 2.
Effect of cytosolic Ca2+ clamp
and Ang II on cholesterol content of submitochondrial fractions of
bovine glomerulosa cells. Stimulation with a cytosolic high
Ca2+ clamp or Ang II and submitochondrial fractionation
were carried out as described under "Experimental Procedures." The
cholesterol content of pooled OM, CS, and IM fractions was determined
and expressed for submitochondrial fractions of high
Ca2+-clamped (A) or Ang II-stimulated
(B) cells (in the absence or presence of 1 mM
CHX) as a percentage of that measured in the respective pooled
submitochondrial fractions of control cells (mean ± S.E.,
n = 4 for Ca2+, n = 4 for
Ang II, and n = 3 for Ca2+ or Ang II + CHX). Mass unit values for cholesterol in OM, CS, and IM were 3.73 ± 0.21, 1.56 ± 0.20, and 0.86 ± 0.22 µg/mg of mitochondrial protein for controls; 1.98 ± 0.36 (***), 2.10 ± 0.16 (**), and 1.05 ± 0.08 (*) µg for CaCl2; and
2.9 ± 0.34, 1.54 ± 0.16, and 0.83 ± 0.15 µg for
CaCl2 + CHX, respectively. Similar values were recorded in
experiments with Ang II. *, **, and ***, significantly different from
the respective control with p < 0.05, p < 0.01, and p < 0.001, respectively.
[View Larger Version of this Image (36K GIF file)]
When CHX was added concomitantly with Ca2+, the decrease in
cholesterol content in the OM fraction was almost entirely prevented (92.5 ± 5.4% of the cholesterol content in the respective
control fraction, n = 3). Simultaneously, CHX reduced
significantly the Ca2+-induced cholesterol increase in CS
and IM (Fig. 2A).
Fig. 2B illustrates the effect of Ang II on the cholesterol
content of submitochondrial fractions of intact glomerulosa cells. No
significant changes were detected in the outer mitochondrial membranes
(93.4 ± 1.0% of controls, n = 4). However, the
hormone induced a pronounced increase in cholesterol content in the
contact site-enriched fractions (151.1 ± 18.1% of controls,
n = 4; p < 0.05). Finally, a less
pronounced increase in cholesterol content was observed in the inner
membrane fractions (124.5 ± 6.5% of controls, n = 4; p < 0.05).
The accumulation of cholesterol in mitochondrial contact sites that
occurred during Ang II stimulation was entirely prevented by
cycloheximide (Fig. 2B). Furthermore, there was a tendency toward an increase in cholesterol content in the outer mitochondrial membranes (110.3 ± 20.3% of controls with Ang II alone,
n = 3).
Ca2+ Stimulates StAR Protein Expression in Bovine
Glomerulosa Cells
The 30-kDa mitochondrial StAR protein has been
recently shown to be required in the acute regulation of steroid
synthesis (18, 19). To determine whether an increase in
[Ca2+]i affected StAR protein expression in
bovine glomerulosa cells, mitochondrial proteins from
Ca2+-clamped cells were analyzed by immunoblotting. Fig.
3A shows the results obtained with one
representative experiment. The anti-StAR protein antibodies recognized
a protein doublet of ~30 kDa in mitochondria from both control cells
and high Ca2+-clamped cells. Densitometric analysis of this
particular Western blot revealed that Ca2+ increased StAR
protein content to 210% of controls. CHX significantly inhibited the
Ca2+-induced increase in StAR protein by 62%. In Fig.
3B, the mean results from the quantitation of the StAR
protein signal in mitochondria from five separate experiments are
represented. Ca2+ increased significantly mitochondrial
StAR protein content to 159 ± 23% of controls (p < 0.05). This effect of Ca2+ was prevented by CHX
(116 ± 8% of controls).
Fig. 3.
Immunodetection of StAR protein in
mitochondria of Ca2+-clamped glomerulosa cells.
A, shown is a Western blot from one representative
experiment. Mitochondria were isolated from control cells or high
Ca2+-clamped cells incubated in the absence or presence of
1 mM CHX. For each sample, 10 µg of mitochondrial
proteins were separated by SDS-polyacrylamide gel electrophoresis as
described under "Experimental Procedures." B, the
immunospecific bands for the 30-kDa StAR proteins were quantitated by
densitometry in five independent experiments. C, control
(low Ca2+ clamp); Ca2+, high calcium
clamp (600 nM); Ca2+ + CHX,
high calcium clamp in the presence of cycloheximide; IOD, integrated optical density.
[View Larger Version of this Image (21K GIF file)]
Ca2+ and Ang II Selectively Increase StAR Protein
Content in Inner Mitochondrial Membranes
We next examined the
submitochondrial distribution of StAR protein in adrenal glomerulosa
cells. Interestingly, no StAR protein was detected in the outer
membrane (data not shown). By contrast, as shown in Fig.
4A, StAR proteins were detected by the
antibody in mitochondrial CS and IM from both control (low
Ca2+-clamped) and high Ca2+-clamped cells.
Densitometric analysis of the immunospecific bands (Fig. 4B)
revealed that no significant changes were observed in StAR protein
content in mitochondrial CS from high Ca2+-clamped cells as
compared with controls. By contrast, Ca2+ increased StAR
protein content by 4-fold in IM, indicating that the increase in StAR
protein induced by Ca2+ was specifically targeted to the
inner mitochondrial membranes. The average Ca2+-induced
StAR protein content in IM from five separate experiment amounted to
228 ± 50% (p < 0.01) (Fig.
5B).
Fig. 4.
Immunodetection of StAR protein in
submitochondrial fractions of Ca2+-clamped glomerulosa
cells. A, 25 µg of protein from CS and IM from one
representative experiment were analyzed by immunoblotting for their
StAR protein content after incubation of glomerulosa cells under a low
or a high Ca2+ clamp. B, shown is the
densitometric analysis of the Western blot. IOD, integrated
optical density.
[View Larger Version of this Image (26K GIF file)]
Fig. 5.
Effect of CHX on Ca2+- and Ang
II-induced increase in StAR protein in IM. Cells were stimulated
for 2 h with Ca2+ or Ang II in the presence or absence
of CHX, and submitochondrial fractions were prepared as described under
"Experimental Procedures." A, 10 µg of inner membrane
protein were analyzed by immunoblotting for StAR protein content.
B, shown is the densitometric analysis of five separate
experiments. C, control (low Ca2+ clamp);
Ca2+, high calcium clamp (600 nM);
Ca2+ + CHX, high calcium clamp in the
presence of cycloheximide. *, p < 0.05. IOD, integrated optical density.
[View Larger Version of this Image (22K GIF file)]
Qualitatively similar results were obtained with Ang II (Fig.
5B). The hormone induced a significant increase in IM StAR
protein to 150 ± 23% of controls (n = 3, p < 0.05), while having no effect on StAR protein
content in CS.
The Ca2+- and Ang II-induced Increase in StAR Protein
Content in Inner Mitochondrial Membranes Is Sensitive to CHX
When
bovine adrenal glomerulosa cells were subjected to a high
Ca2+ clamp in the presence of CHX, immunoblot analysis of
inner mitochondrial membrane and contact site proteins revealed that
CHX completely prevented the Ca2+-induced increase in StAR
protein in IM (Fig. 5, A and B), while no
significant changes occurred in contact sites (data not shown). Similarly, the increase in IM StAR protein content observed after Ang
II challenge was not observed in the presence of CHX (Fig. 5B).
Cytochrome P450scc and 3 -HSD Are Found in
Mitochondrial Contact Sites and Inner Membranes
To determine
whether StAR protein induction by Ca2+ and Ang II was
specific, submitochondrial fractions were analyzed by immunoblotting using anti-3 -HSD or anti-P450scc antibodies since we had
shown previously that these two enzymes are co-localized within the mitochondria of bovine fasciculata cells (27). The increase in the
synthesis of these two enzymes is known to require long-term exposure
to steroidogenic hormones (9). Fig. 6 shows that
mitochondrial contact sites and inner membranes from bovine glomerulosa
cells contain significant amounts of 3 -HSD and P450scc.
In addition, no changes in 3 -HSD and P450scc content
occurred in these submitochondrial fractions with Ang II stimulation.
Finally, CHX did not affect the level of these proteins in CS and IM.
Identical observations were made in bovine glomerulosa cells subjected
to a high Ca2+ clamp (data not shown).
Fig. 6.
Immunodetection of 3 -HSD and cytochrome
P450scc in submitochondrial fractions of Ang II-stimulated
glomerulosa cells. Submitochondrial fractions were prepared after
stimulation for 2 h with Ang II, and proteins were separated by
SDS-polyacrylamide gel electrophoresis as described under
"Experimental Procedures." 10 µg of protein from CS and IM were
analyzed by immunoblotting for their 3 -HSD and cytochrome
P450scc content. This Western blot is representative of
three similar experiments. C, control.
[View Larger Version of this Image (49K GIF file)]
The presence of 3 -HSD in inner mitochondrial membranes from bovine
glomerulosa cells was further confirmed by preparing mitoplasts. The
determination of enzyme marker activities confirmed that mitoplasts were practically devoid of any contamination with microsomes. Indeed,
as can be seen in Table I, while cytochrome c
oxidase activity was 10-fold higher in mitoplasts than in outer
membranes, NADPH-cytochrome c reductase activity, a marker
of the endoplasmic reticulum, was undetectable in mitoplasts and high
in microsomes. Upon immunoblot analysis (Fig.
7A), a strong 3 -HSD signal was detected in
mitoplasts as well as in microsomes, thus confirming the presence of
the enzyme inside the mitochondria. In fact, the 3 -HSD signal in
mitoplasts was considerably higher than in outer membranes in spite of
the fact that the latter displayed a higher NADPH-cytochrome
c reductase activity.
Table I.
Enzyme marker activities in mitoplasts, outer mitochondrial membranes,
and microsomes
Cytochrome c oxidase and NADPH-cytochrome c
reductase activities were determined after preparation of mitoplasts as
described under "Experimental Procedures." Each value is the
mean ± S.E. of duplicate determinations from two separate
experiments.
|
COXa |
NADPH-cytochrome c reductase
|
|
|
nmol/min/mg
protein |
nmol/min/mg protein |
| Outer
membranes |
183.5 ± 57.5 |
2.9 ± 0.2
|
| Mitoplasts |
1746 ± 136 |
ND
|
| Microsomes |
ND |
16.3 ± 1.6 |
|
|
a
COX, cytochrome c oxidase; ND, not
detectable.
|
|
Fig. 7.
Intramitochondrial localization of 3 -HSD
in bovine glomerulosa cells and in MA-10 mouse Leydig cells.
A, mitoplasts were prepared from bovine glomerulosa cells as
described under "Experimental Procedures," and 5 µg of protein of
outer membranes (lane 1), mitoplasts (lane 2), or
microsomes (lane 3) were analyzed by immunoblotting for
their 3 -HSD content. B, shown is a Western blot of
3 -HSD and cytochrome c oxidase (COX) in
submitochondrial fractions of MA-10 mouse Leydig cells. Mitochondria
were fractionated on a sucrose density gradient as described under
"Experimental Procedures," and 10 µg of protein from each
fraction (lanes 1-18) were analyzed by
immunoblotting.
[View Larger Version of this Image (52K GIF file)]
To examine whether the intramitochondrial localization of 3 -HSD is a
common characteristic of steroidogenic cells, mitochondria from MA-10
mouse Leydig cells were fractionated on a sucrose gradient as described
above for adrenal mitochondria. As shown in Fig. 7B,
immunoblot analysis revealed the presence of the 3 -HSD protein in CS
and IM, but not in OM.
Immunocytochemical Localization of 3 -HSD
As an additional
proof of the presence of 3 -HSD within steroidogenic mitochondria,
the ultrastructural localization of 3 -HSD was studied by the
immunogold staining technique in rat adrenal fasciculata cells (17,
34). Fig. 8 shows that 3 -HSD antigenic sites are
clearly abundant in the mitochondria of these cells. The
immunovisualization technique also confirms that, as expected, >60%
of this enzyme is anchored to the membranes of the endoplasmic reticulum (Fig. 8C and Table II), where the
apparent density of immunoreactive 3 -HSD is 56% higher than that
observed in the mitochondria (Table II). Higher enrichment of
membrane-bound 3 -HSD was observed in stacking of smooth endoplasmic
reticulum shown in Fig. 8C. Quantitation of
P450scc labeling, which serves as a classical mitochondrial
marker, shows a dramatically reciprocated ratio, with the density of
this enzyme per mitochondrial surface being 10 times higher than that
observed in the cytoplasm (Table II).
Table II.
Distribution of colloidal gold-labeled 3 -HSD in endoplasmic
reticulum versus intramitochondrial sections
The low power photomicrographs shown in Fig. 8 (A and
B) were scanned and analyzed as described under
"Experimental Procedures." The localization of the gold particles
was categorized as shown, and the relative area of each cellular
compartment was defined. The particle number (percent in parentheses)
and the density per unit area are shown.
| Localization |
Relative
area |
No. particles |
Particles/area |
|
3 -HSD (Fig.
8A)
|
| Mitochondria |
0.43 |
1218 (39.9%) |
2800
|
| ERa |
0.42 |
1836 (60.1%) |
4371 |
| Cytoplasm
|
| Fat, ICS |
0.15 |
1 |
0 |
| P450scc (Fig.
8B) |
| Mitochondria |
0.35 |
5.036 (86%) |
14,388
|
| ER |
| Cytoplasm |
0.53 |
790 (14%) |
1490 |
| Fat,
ICS |
0.1 |
5 |
0 |
|
|
a
ER, endoplasmic reticulum; cytoplasm, defined as such
when ultrastructural preservation did not allow a clear definition of the endoplasmic reticulum; fat, lipid droplets as shown in Fig. 8
(A and B); ICS, intercellular spaces.
|
|
The intramitochondrial pattern of 3 -HSD localization (Fig.
8D) was monitored using an analytical approach similar to
that previously applied to P450scc and StAR protein
patterns (34, 36). Fig. 9 depicts the
compartmentalization patterns of the three key steroidogenic proteins
at a submitochondrial resolution. Clearly, whereas P450scc
antigenic sites were exclusively anchored to the crista membranes
protruding into the mitochondrial matrix (34), the labeling of 3 -HSD
sites partitioned in all five compartments of the organelle.
Nevertheless, nearly 60% of 3 -HSD labeling was associated with the
crista membranes, whereas the rest of the antigenic sites were equally
distributed between the outer membranes, the mitochondrial matrix, and
the intermembrane spaces. To some extent, this profile of 3 -HSD
sites also differed from that obtained for StAR protein, the majority
of which was confined to the intermembrane spaces of the vesicular
cristae (Fig. 9).
Fig. 9.
Intramitochondrial distribution of colloidal
gold-labeled 3 -HSD, P450scc, and StAR protein.
Colloidal gold particles were manually counted in 6-10 different
mitochondria of rat adrenal fasciculata cells stained with rabbit
antisera to bovine 3 -HSD, rat P450scc (based on
previously published data (34)), and mouse StAR (based on previously
published data (17)) (787, 587, and 443 particles, respectively). The
localization of the particles in five different intramitochondrial
compartments was categorized using high power photomicrographs
(magnification × 50,575) as described for Fig. 8D.
Data are presented as percentage (mean ± S.E.) of gold particles
in each of the submitochondrial compartments. IMS,
intermembrane spaces.
[View Larger Version of this Image (27K GIF file)]
DISCUSSION
In a previous study on the mechanisms of activation of aldosterone
biosynthesis by Ca2+, we have narrowed the potential target
domain for this messenger to the early steps of the steroidogenic
pathway (24). Using the ionomycin-mediated Ca2+ clamp and
Ang II as activators of steroid synthesis in bovine glomerulosa cells,
we have recently shown that physiological [Ca2+]i
changes acutely stimulate cholesterol redistribution across
mitochondrial membranes (37). We now demonstrate that this cholesterol
transfer from the outer mitochondrial membranes to both contact sites
and inner membranes is associated with a selective increase in StAR
protein content in inner mitochondrial membranes and that both these
responses require protein synthesis.
The major finding of this work is the clear-cut and specific increase
in the mature form(s) of the 30-kDa StAR protein in the inner
mitochondrial membranes of bovine glomerulosa cells under stimulation
of the calcium messenger system. To our knowledge, this is the first
demonstration of a submitochondrial modulation of StAR protein by
Ca2+. Indeed, most studies that have investigated the
regulation of the 30-kDa proteins involved in the acute steroidogenic
response have used total cellular or mitochondrial protein extracts and have focused on trophic agents activating adenylyl cyclase and cAMP
production (16, 38, 39). Recently, Clark et al. (40) have
shown that calcium-mobilizing agonists such as Ang II, K+,
and the dihydropyridine agonist Bay K8644 produce significant increases
in the cellular levels of StAR protein in H295R human adenocarcinoma
cells within 4-6 h. Our results extend this observation by confining
the StAR protein increase to a submitochondrial compartment and by
showing that it can be observed after shorter stimulation times (2 h),
thus confirming the acute role of StAR protein in the initiation of the
steroidogenic response.
In MA-10 Leydig tumor cells and in the human H295R adrenocarcinoma cell
line, StAR protein appears as a single band upon immunoblot analysis
(16, 40), whereas in bovine adrenal glomerulosa cells, we detected a
StAR protein doublet around 30 kDa. While the nature of this protein
doublet remains to be elucidated, it is worth mentioning that a similar
pattern has been observed in bovine fasciculata cells (41). In MA-10
mouse Leydig tumor cells, phosphorylation of StAR protein on a
threonine residue is required for the acute induction of
steroidogenesis (42). The doublet we observed may therefore represent
phosphorylated and non-phosphorylated forms of StAR protein. These
proteins could also be related to the 28.5-30-kDa proteins shown by
Elliott et al. (43) to be induced by Ang II in bovine
glomerulosa cells.
Remarkably, Ca2+ and Ang II induced StAR protein
accumulation exclusively in the inner mitochondrial membranes.
Interestingly, although StAR protein was present in contact sites, the
increase in cholesterol induced by [Ca2+]i rises
was not associated with a concomitant increase in StAR protein content,
indicating that StAR protein is only transiting via those structures.
Moreover, we could not detect the 37-kDa precursor of StAR protein in
any of the submitochondrial fractions. These observations confirm the
short half-life of the StAR protein precursor, which is known to be
rapidly processed by mitochondrial proteases (17), and indicate that
the inner mitochondrial membranes constitute the final destination of
mature StAR protein. The present biochemical evidence is therefore in agreement with our visualization of StAR protein localization in
adrenal mitochondria labeled by immunogold staining (17).
Early studies in adrenocortical cells have demonstrated that the
inhibitor of protein translation, cycloheximide, prevents the increase
in the rate of steroid synthesis induced by ACTH (10, 11). The
cycloheximide-sensitive step in steroidogenesis has been located to the
ACTH-activated cholesterol transport to the inner mitochondrial
membrane (10). In adrenal glomerulosa cells, Elliott and Goodfriend
(44) have reported that the cycloheximide-sensitive step in Ang
II-stimulated aldosterone synthesis is mitochondrial pregnenolone
synthesis, the first event in steroidogenesis following cholesterol
supply to cytochrome P450scc. Activators of steroidogenesis mobilizing either the cAMP or the Ca2+ messenger system
have been shown to induce a net accumulation of total cellular StAR
protein (19, 40), and we have obtained similar data in bovine
glomerulosa cells (data not shown). These findings indicate that
cycloheximide is most likely to act at a translational level. Indeed,
our data show that both StAR protein accumulation and
intramitochondrial cholesterol transfer induced by
[Ca2+]i rises are highly sensitive to
cycloheximide, strongly suggesting that the blockade of StAR protein
synthesis prevents cholesterol mobilization to the inner membranes.
Taken together, these results provide strong correlative evidence that
the increase in StAR protein expression and its targeting to the
mitochondrial membranes are linked to cholesterol redistribution from
the outer to the inner membranes induced by calcium-mobilizing agents
in adrenal glomerulosa cells.
Our current model of the mechanisms of calcium-induced activation of
steroidogenesis would favor a dual site of action for Ca2+:
in addition to an obligatory role for Ca2+ influx into the
mitochondria, as demonstrated previously in permeabilized glomerulosa
cells (45) and in glomerulosa cells treated with a blocker of the
mitochondrial Na+/Ca2+ exchanger (25), the
present cycloheximide results imply an effect of cytosolic
Ca2+ on StAR protein expression.
The effect of increased [Ca2+]i is shown to be
specific for StAR protein since the levels of two additional key
steroidogenic enzymes in the mitochondria, cytochrome
P450scc and 3 -HSD, were not affected under similar
experimental manipulations. It should be noted that whereas
P450scc is a typical nuclearly encoded mitochondrial protein, 3 -HSD has been considered as an enzyme anchored in the endoplasmic reticulum (46), with a few exceptions (47). Yet, we have
previously provided evidence showing that P450scc and 3 -HSD co-localize in the inner membranes and contact sites of bovine
adrenocortical zona fasciculata mitochondria (27), and their
association into a macromolecular complex retains the catalytic activities of both enzymes (48). We report here that cytochrome P450scc and 3 -HSD also coexist in the contact sites and
inner membranes of zona glomerulosa mitochondria. In addition,
immunogold staining of rat adrenal fasciculata mitochondria, as well as
immunoblot analysis of MA-10 mouse Leydig submitochondrial fractions,
clearly confirmed the intramitochondrial localization of 3 -HSD. The
consistency of this finding, observed with different techniques in
various steroidogenic cell types from three different species, speaks in favor of a common feature of 3 -HSD distribution in all
steroid-producing cells. Although the N terminus of the 3 -HSD
protein does not appear to include a mitochondrial targeting sequence
(49), various proteins of the inner mitochondrial membrane, such as the
ADP/ATP carrier (50), porin (51), and BCS1 (52), appear to contain important targeting information either internally or at their C
terminus, rather than at the N terminus (53). The intramitochondrial presence of 3 -HSD could add a facilitating step of important functional significance to the Ca2+-mediated cholesterol
transfer: channeling pregnenolone to progesterone should be highly
favored by 3 -HSD located in close proximity to P450scc
and may actually represent a major pathway, in line with the fact that
pregnenolone is the preferential substrate of mitochondrial 3 -HSD
(27). In this regard, it is worth mentioning that the existence of
multihormonal enzyme complexes ("hormonads") has already been
proposed some years ago by Lieberman and Prasad (54) and Prasad
et al. (55).
Collectively, our biochemical approaches, together with the
ultrastructural analysis showing that >85% of P450scc and
60% of mitochondrial 3 -HSD are anchored to the inner crista
membranes of this organelle, raise the possibility of a supramolecular
organization of P450scc and 3 -HSD into a functional unit
directly catalyzing the metabolism of cholesterol to pregnenolone and
to progesterone following StAR protein-mediated cholesterol supply via
contact sites.
FOOTNOTES
*
This work was supported in part by Swiss National Science
Foundation Grants 31.42178-94 (to A. M. C.) and 32.39277-93 (to M. F. R.), by National Institutes of Health Grant HD 17841 (to D. M. S.), and by United States-Israel Binational Science Foundation Grant 95-350 (to J. O.).The costs of publication of this
article were defrayed in part by the
payment of page charges. The article must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
§
To whom correspondence should be addressed: Div. of Endocrinology
and Diabetology, University Hospital, 24, rue Micheli-du-Crest, CH-1211
Geneva 14, Switzerland. Tel.: 4122-372-93-21; Fax: 4122-372-93-29; E-mail: cherradi-nadia{at}diogenes.hcuge.ch.
¶
Recipient of a grant from the Prof. Max Cloëtta
Foundation.
1
The abbreviations used are: Ang II, angiotensin
II; ACTH, adrenocorticotropic hormone; OM, outer mitochondrial
membrane(s); IM, inner mitochondrial membrane(s); CS, intermembrane
contact sites; StAR, steroidogenic acute regulatory;
[Ca2+]i, cytosolic free calcium concentration;
3 -HSD, 3 -hydroxysteroid dehydrogenase isomerase; CHX,
cycloheximide.
Acknowledgments
We are grateful to Liliane Bockhorn, Walda
Dimeck, Gisèle Dorenter, Marcella Klein, and Maria Lopez for
excellent technical assistance.
REFERENCES
-
Capponi, A. M., Lew, P. D., Jornot, L., and Vallotton, M. B.
(1984)
J. Biol. Chem.
259,
8863-8869
[Abstract/Free Full Text]
-
Quinn, S. J., Williams, G. H., and Tillotson, D. L.
(1988)
Am. J. Physiol.
255,
E488-E495
[Abstract/Free Full Text]
-
Müller, J.
(1988)
Regulation of Aldosterone Biosynthesis, 2nd Ed., Springer-Verlag, Berlin
-
Barrett, P. Q., Bollag, W. B., Isales, C. M., McCarthy, R. T., and Rasmussen, H.
(1989)
Endocr. Rev.
10,
496-518
[Abstract/Free Full Text]
-
Spät, A., Enyedi, P., Hajnoczky, G., and Hunyady, L.
(1991)
Exp. Physiol.
76,
859-885
[Medline]
[Order article via Infotrieve]
-
Fakunding, J. L., Chow, R., and Catt, K. J.
(1979)
Endocrinology
105,
327-333
[Abstract/Free Full Text]
-
Wilson, J. X., Aguilera, G., and Catt, K. J.
(1984)
Endocrinology
115,
1357-1363
[Abstract/Free Full Text]
-
Jefcoate, C. R., McNamara, B. C., Artemenko, I., and Yamazaki, T.
(1992)
J. Steroid. Biochem. Mol. Biol.
43,
751-767
[CrossRef]
-
Orme-Johnson, N. R.
(1990)
Biochim. Biophys. Acta
1020,
213-231
[Medline]
[Order article via Infotrieve]
-
Privalle, C. T., Crivello, J. F., and Jefcoate, C. R.
(1983)
Proc. Natl. Acad. Sci. U. S. A.
80,
702-706
[Abstract/Free Full Text]
-
Privalle, C. T., McNamara, B. C., Dhariwal, M. S., and Jefcoate, C. R.
(1987)
Mol. Cell. Endocrinol.
53,
87-101
[CrossRef][Medline]
[Order article via Infotrieve]
-
Epstein, L. F., and Orme-Johnson, N. R.
(1991)
J. Biol. Chem.
266,
19739-19745
[Abstract/Free Full Text]
-
Alberta, J. A., Epstein, L. F., Pon, L. A., and Orme-Johnson, N. R.
(1989)
J. Biol. Chem.
264,
2368-2372
[Abstract/Free Full Text]
-
Stocco, D. M., and Sodeman, T. C.
(1991)
J. Biol. Chem.
266,
19731-19739
[Abstract/Free Full Text]
-
Stocco, D. M.
(1992)
J. Steroid Biochem. Mol. Biol.
43,
319-333
[CrossRef][Medline]
[Order article via Infotrieve]
-
Clark, B. J., Wells, J., King, S. R., and Stocco, D. M.
(1994)
J. Biol. Chem.
269,
28314-28322
[Abstract/Free Full Text]
-
King, S. R., Ronen-Fuhrmann, T., Timberg, R., Clark, B. J., Orly, J., and Stocco, D. M.
(1995)
Endocrinology
136,
5165-5176
[Abstract]
-
Stocco, D. M., and Clark, B. J.
(1996)
Biochem. Pharmacol.
51,
197-205
[CrossRef][Medline]
[Order article via Infotrieve]
-
Stocco, D. M., and Clark, B. J.
(1996)
Endocr. Rev.
17,
221-244
[Abstract/Free Full Text]
-
Lin, D., Sugawara, T., Strauss, J. F., Clark, B. J., Stocco, D. M., Saenger, P., Rogol, A., and Miller, W. L.
(1995)
Science
267,
1828-1831
[Abstract/Free Full Text]
-
Portat-Doven, S., Leheup, B., Chaussain, J.-L., and Morel, Y. (1996)
Program of the 10th International Congress of Endocrinology, San
Francisco, CA, June 12-15, 1996, Abstr. P2-726
-
Bose, H. S., Sugawara, T., Strauss, J. F., and Miller, W. L.
(1996)
N. Engl. J. Med.
335,
1870-1878
[Abstract/Free Full Text]
-
Katsumata, N., Tanae, A., Shinagawa, T., Yasunaga, T., Tanaka, T., and
Hibi, I. (1996) Program of the 10th International Congress of
Endocrinology, San Francisco, CA, Abstr. P3-564
-
Python, C. P., Laban, O. P., Rossier, M. F., Vallotton, M. B., and Capponi, A. M.
(1995)
Biochem. J.
305,
569-576
-
Brandenburger, Y., Kennedy, E. D., Python, C. P., Rossier, M. F.,
Vallotton, M. B., Wollheim, C. B., and Capponi, A. M. (1996)
Endocrinology, in press
-
Johnson, E. I. M., Capponi, A. M., and Vallotton, M. B.
(1989)
J. Endocrinol.
122,
391-402
[Abstract/Free Full Text]
-
Cherradi, N., Defaye, G., and Chambaz, E. M.
(1994)
Endocrinology
134,
1358-1364
[Abstract/Free Full Text]
-
Appelmans, F., Wattiaux, R., and De Duve, C.
(1955)
Biochem. J.
59,
438-445
[Medline]
[Order article via Infotrieve]
-
Otsuka, S., and Kobayashi, Y.
(1964)
Biochem. Pharmacol.
13,
995-1006
-
Sottocasa, G. L., Kuylenstierna, B., Ernster, L., and Bergstrand, A.
(1967)
J. Cell Biol.
32,
415-438
[Abstract/Free Full Text]
-
Gamble, W., Vaughan, M., Kruth, H. S., and Avigan, J.
(1978)
J. Lipid Res.
19,
1068-1070
[Abstract]
-
Laemmli, U. K.
(1970)
Nature
227,
680-685
[CrossRef][Medline]
[Order article via Infotrieve]
-
Towbin, H., Staehelin, T., and Gordon, J.
(1979)
Proc. Natl. Acad. Sci. U. S. A.
76,
4350-4354
[Abstract/Free Full Text]
-
Farkash, Y., Timberg, R., and Orly, J.
(1986)
Endocrinology
118,
1353-1365
[Abstract/Free Full Text]
-
Newman, G. R., Jasani, B., and Williams, E. D.
(1983)
Histochem. J.
15,
543-555
[CrossRef][Medline]
[Order article via Infotrieve]
-
Roth, J.
(1989)
in
Techniques in Immunochemistry (Bullock, G. R. B., and Petrusz, P., eds), pp. 107-134, Academic Press Ltd., London
-
Cherradi, N., Rossier, M. F., Vallotton, M. B., and Capponi, A. M.
(1996)
J. Biol. Chem.
271,
25971-25975
[Abstract/Free Full Text]
-
Stocco, D. M., and Ascoli, M.
(1993)
Endocrinology
132,
959-967
[Abstract/Free Full Text]
-
Sugawara, T., Holt, J. A., Driscoll, D., Strauss, J. F., Lin, D., Miller, W., Patterson, D., Clancy, K. P., Hart, I. M., Clark, B. J., and Stocco, D. M.
(1995)
Proc. Natl. Acad. Sci. U. S. A.
92,
4778-4782
[Abstract/Free Full Text]
-
Clark, B. J., Pezzi, V., Stocco, D. M., and Rainey, W. E.
(1995)
Mol. Cell. Endocrinol.
115,
215-219
[CrossRef][Medline]
[Order article via Infotrieve]
-
Nishikawa, T., Sasano, H., Omura, M., and Suematsu, S.
(1996)
Biochem. Biophys. Res. Commun.
223,
12-18
[CrossRef][Medline]
[Order article via Infotrieve]
-
Stocco, D. M., and Clark, B. J.
(1993)
J. Steroid Biochem. Mol. Biol.
46,
337-347
[CrossRef][Medline]
[Order article via Infotrieve]
-
Elliott, M. E., Goodfriend, T. L., and Jefcoate, C. R.
(1993)
Endocrinology
133,
1669-1677
[Abstract/Free Full Text]
-
Elliott, M. E., and Goodfriend, T. L.
(1984)
Biochem. Pharmacol.
33,
1519-1524
[CrossRef][Medline]
[Order article via Infotrieve]
-
Capponi, A. M., Rossier, M. F., Davies, E., and Vallotton, M. B.
(1988)
J. Biol. Chem.
263,
16113-16117
[Abstract/Free Full Text]
-
Ishimura, K., Yoshinaga-Hirabayashi, T., Fujita, H., Ishii-Ohba, H., Inano, H., and Tamaoki, B.
(1988)
Histochemistry
89,
35-39
[CrossRef][Medline]
[Order article via Infotrieve]
-
Chapman, J. C., and Sauer, L. A.
(1979)
J. Biol. Chem.
254,
6624-6630
[Free Full Text]
-
Cherradi, N., Chambaz, E. M., and Defaye, G.
(1995)
J. Steroid Biochem. Mol. Biol.
55,
507-514
[CrossRef][Medline]
[Order article via Infotrieve]
-
Labrie, F., Simard, J., Luu-The, V., Bélanger, A., and Pelletier, G.
(1992)
J. Steroid Biochem. Mol. Biol.
43,
805-826
[CrossRef]
-
Pfanner, N., Hoeben, P., Tropschug, M., and Neupert, W.
(1987)
J. Biol. Chem.
262,
14851-14854
[Abstract/Free Full Text]
-
Court, D. A., Kleene, R., Neupert, W., and Lill, R.
(1996)
FEBS Lett.
390,
73-77
[CrossRef][Medline]
[Order article via Infotrieve]
-
Folsch, H., Guiard, B., Neupert, W., and Stuart, R. A.
(1996)
EMBO J.
15,
479-487
[Medline]
[Order article via Infotrieve]
-
Stuart, R. A., and Neupert, W.
(1996)
Trends Biochem. Sci.
21,
261-267
[CrossRef][Medline]
[Order article via Infotrieve]
-
Lieberman, S., and Prasad, V. V. K.
(1990)
Endocr. Rev.
11,
469-493
[Abstract/Free Full Text]
-
Prasad, V. K. K., Mathur, C., Welch, M., and Lieberman, S.
(1992)
Proc. Natl. Acad. Sci. U. S. A.
89,
4173-4177
[Abstract/Free Full Text]
©1997 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
E. F Nogueira, Y. Xing, C. A V Morris, and W. E Rainey
Role of angiotensin II-induced rapid response genes in the regulation of enzymes needed for aldosterone synthesis
J. Mol. Endocrinol.,
April 1, 2009;
42(4):
319 - 330.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Lenglet, F. Antigny, L. Vetterli, J.-F. Dufour, and M. F. Rossier
Hint2 Is Expressed in the Mitochondria of H295R Cells and Is Involved in Steroidogenesis
Endocrinology,
November 1, 2008;
149(11):
5461 - 5469.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. J. Casal, S. Ryser, A. M. Capponi, and C. F. Wang-Buholzer
Angiotensin II-Induced Mitogen-Activated Protein Kinase Phosphatase-1 Expression in Bovine Adrenal Glomerulosa Cells: Implications in Mineralocorticoid Biosynthesis
Endocrinology,
November 1, 2007;
148(11):
5573 - 5581.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Z. Granot, O. Kobiler, N. Melamed-Book, S. Eimerl, A. Bahat, B. Lu, S. Braun, M. R. Maurizi, C. K. Suzuki, A. B. Oppenheim, et al.
Turnover of Mitochondrial Steroidogenic Acute Regulatory (StAR) Protein by Lon Protease: The Unexpected Effect of Proteasome Inhibitors
Mol. Endocrinol.,
September 1, 2007;
21(9):
2164 - 2177.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. L. Miller
StAR Search--What We Know about How the Steroidogenic Acute Regulatory Protein Mediates Mitochondrial Cholesterol Import
Mol. Endocrinol.,
March 1, 2007;
21(3):
589 - 601.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. R. Pepperell, G. Nemeth, Y. Yamada, F. Naftolin, and M. Merino
Localized accumulation of angiotensin II and production of angiotensin-(1-7) in rat luteal cells and effects on steroidogenesis
Am J Physiol Endocrinol Metab,
August 1, 2006;
291(2):
E221 - E233.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Assie, C. Auzan, J.-M. Gasc, E. Baviera, A. Balaton, J.-M. Elalouf, X. Jeunemaitre, P.-F. Plouin, P. Corvol, and E. Clauser
Steroidogenesis in Aldosterone-Producing Adenoma Revisited by Transcriptome Analysis
J. Clin. Endocrinol. Metab.,
December 1, 2005;
90(12):
6638 - 6649.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Simard, M.-L. Ricketts, S. Gingras, P. Soucy, F. A. Feltus, and M. H. Melner
Molecular Biology of the 3{beta}-Hydroxysteroid Dehydrogenase/{Delta}5-{Delta}4 Isomerase Gene Family
Endocr. Rev.,
June 1, 2005;
26(4):
525 - 582.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Otis, S. Campbell, M. D. Payet, and N. Gallo-Payet
Angiotensin II Stimulates Protein Synthesis and Inhibits Proliferation in Primary Cultures of Rat Adrenal Glomerulosa Cells
Endocrinology,
February 1, 2005;
146(2):
633 - 642.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. F. Buholzer, J.-F. Arrighi, S. Abraham, V. Piguet, A. M. Capponi, and A. J. Casal
Chicken Ovalbumin Upstream Promoter-Transcription Factor Is a Negative Regulator of Steroidogenesis in Bovine Adrenal Glomerulosa Cells
Mol. Endocrinol.,
January 1, 2005;
19(1):
65 - 75.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. H. Payne and D. B. Hales
Overview of Steroidogenic Enzymes in the Pathway from Cholesterol to Active Steroid Hormones
Endocr. Rev.,
December 1, 2004;
25(6):
947 - 970.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Jo and D. M. Stocco
Regulation of Steroidogenesis and Steroidogenic Acute Regulatory Protein in R2C Cells by DAX-1 (Dosage-Sensitive Sex Reversal, Adrenal Hypoplasia Congenita, Critical Region on the X Chromosome, Gene-1)
Endocrinology,
December 1, 2004;
145(12):
5629 - 5637.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. G. Romero, M. Plonczynski, G. R. Vergara, E. P. Gomez-Sanchez, and C. E. Gomez-Sanchez
Angiotensin II early regulated genes in H295R human adrenocortical cells
Physiol Genomics,
September 16, 2004;
19(1):
106 - 116.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. SPAT and L. HUNYADY
Control of Aldosterone Secretion: A Model for Convergence in Cellular Signaling Pathways
Physiol Rev,
April 1, 2004;
84(2):
489 - 539.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Z. Granot, R. Geiss-Friedlander, N. Melamed-Book, S. Eimerl, R. Timberg, A. M. Weiss, K. H. Hales, D. B. Hales, D. M. Stocco, and J. Orly
Proteolysis of Normal and Mutated Steroidogenic Acute Regulatory Proteins in the Mitochondria: the Fate of Unwanted Proteins
Mol. Endocrinol.,
December 1, 2003;
17(12):
2461 - 2476.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Cherradi, B. Pardo, A. S. Greenberg, F. B. Kraemer, and A. M. Capponi
Angiotensin II Activates Cholesterol Ester Hydrolase in Bovine Adrenal Glomerulosa Cells through Phosphorylation Mediated by p42/p44 Mitogen-Activated Protein Kinase
Endocrinology,
November 1, 2003;
144(11):
4905 - 4915.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Chiyo, T. Yamazaki, K. Aoshika, S. Kominami, and Y. Ohta
Corticosterone Enhances Adrenocorticotropin-Induced Calcium Signals in Bovine Adrenocortical Cells
Endocrinology,
August 1, 2003;
144(8):
3376 - 3381.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Osman, C. Murigande, A. Nadakal, and A. M. Capponi
Repression of DAX-1 and Induction of SF-1 Expression. TWO MECHANISMS CONTRIBUTING TO THE ACTIVATION OF ALDOSTERONE BIOSYNTHESIS IN ADRENAL GLOMERULOSA CELLS
J. Biol. Chem.,
October 18, 2002;
277(43):
41259 - 41267.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Eimerl and J. Orly
Regulation of Steroidogenic Genes by Insulin-Like Growth Factor-1 and Follicle-Stimulating Hormone: Differential Responses of Cytochrome P450 Side-Chain Cleavage, Steroidogenic Acute Regulatory Protein, and 3{beta}-Hydroxysteroid Dehydrogenase/Isomerase in Rat Granulosa Cells
Biol Reprod,
September 1, 2002;
67(3):
900 - 910.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S.-J. Tsai, M.-H. Wu, C.-C. Lin, H. S. Sun, and H.-M. Chen
Regulation of Steroidogenic Acute Regulatory Protein Expression and Progesterone Production in Endometriotic Stromal Cells
J. Clin. Endocrinol. Metab.,
December 1, 2001;
86(12):
5765 - 5773.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Cherradi, M. Bideau, S. Arnaudeau, N. Demaurex, R. W. James, S. Azhar, and A. M. Capponi
Angiotensin II Promotes Selective Uptake of High Density Lipoprotein Cholesterol Esters in Bovine Adrenal Glomerulosa and Human Adrenocortical Carcinoma Cells Through Induction of Scavenger Receptor Class B Type I
Endocrinology,
October 1, 2001;
142(10):
4540 - 4549.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. M. Stocco
Tracking the Role of a StAR in the Sky of the New Millennium
Mol. Endocrinol.,
August 1, 2001;
15(8):
1245 - 1254.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Kimoto, T. Tsurugizawa, Y. Ohta, J.'y. Makino, H.-o. Tamura, Y. Hojo, N. Takata, and S. Kawato
Neurosteroid Synthesis by Cytochrome P450-Containing Systems Localized in the Rat Brain Hippocampal Neurons: N-Methyl-D-Aspartate and Calcium-Dependent Synthesis
Endocrinology,
August 1, 2001;
142(8):
3578 - 3589.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M.-C. Huang and W. L. Miller
Creation and Activity of COS-1 Cells Stably Expressing the F2 Fusion of the Human Cholesterol Side-Chain Cleavage Enzyme System
Endocrinology,
June 1, 2001;
142(6):
2569 - 2576.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Venkatesh, G. Siddhartha, R. Joshi, S. Patel, and G. Hasan
Interactions Between the Inositol 1,4,5-Trisphosphate and Cyclic AMP Signaling Pathways Regulate Larval Molting in Drosophila
Genetics,
May 1, 2001;
158(1):
309 - 318.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
P. R. Manna, T. El-Hefnawy, J. Kero, and I. T. Huhtaniemi
Biphasic Action of Prolactin in the Regulation of Murine Leydig Tumor Cell Functions
Endocrinology,
January 1, 2001;
142(1):
308 - 318.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Boerboom and J. Sirois
Equine P450 Cholesterol Side-Chain Cleavage and 3{beta}-Hydroxysteroid Dehydrogenase/{{Delta}}5-{{Delta}}4 Isomerase: Molecular Cloning and Regulation of Their Messenger Ribonucleic Acids in Equine Follicles During the Ovulatory Process
Biol Reprod,
January 1, 2001;
64(1):
206 - 215.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
F. C. L. Jayes, R. N. Day, J. C. Garmey, R. J. Urban, G. Zhang, and J. D. Veldhuis
Calcium Ions Positively Modulate Follicle-Stimulating Hormone- and Exogenous Cyclic 3',5'-Adenosine Monophosphate-Driven Transcription of the P450scc Gene in Porcine Granulosa Cells
Endocrinology,
July 1, 2000;
141(7):
2377 - 2384.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. C. White and P. W. Speiser
Congenital Adrenal Hyperplasia due to 21-Hydroxylase Deficiency
Endocr. Rev.,
June 1, 2000;
21(3):
245 - 291.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
C. Le Roy, J. Y. Li, D. M. Stocco, D. Langlois, and J. M. Saez
Regulation by Adrenocorticotropin (ACTH), Angiotensin II, Transforming Growth Factor-{beta}, and Insulin-Like Growth Factor I of Bovine Adrenal Cell Steroidogenic Capacity and Expression of ACTH Receptor, Steroidogenic Acute Regulatory Protein, Cytochrome P450c17, and 3{beta}-Hydroxysteroid Dehydrogenase
Endocrinology,
May 1, 2000;
141(5):
1599 - 1607.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Arensburg, A. H. Payne, and J. Orly
Expression of Steroidogenic Genes in Maternal and Extraembryonic Cells During Early Pregnancy in Mice
Endocrinology,
November 1, 1999;
140(11):
5220 - 5232.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
E. Silverman, S. Eimerl, and J. Orly
CCAAT Enhancer-binding Protein beta and GATA-4 Binding Regions within the Promoter of the Steroidogenic Acute Regulatory Protein (StAR) Gene Are Required for Transcription in Rat Ovarian Cells
J. Biol. Chem.,
June 18, 1999;
274(25):
17987 - 17996.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. C. Lee, W. L. Miller, and R. J. Auchus
Medroxyprogesterone Acetate and Dexamethasone Are Competitive Inhibitors of Different Human Steroidogenic Enzymes
J. Clin. Endocrinol. Metab.,
June 1, 1999;
84(6):
2104 - 2110.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
M. Kanzaki and P. L. Morris
Growth Hormone Regulates Steroidogenic Acute Regulatory Protein Expression and Steroidogenesis in Leydig Cell Progenitors
Endocrinology,
April 1, 1999;
140(4):
1681 - 1686.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
P. R. Manna, P. Pakarinen, T. El-Hefnawy, and I. T. Huhtaniemi
Functional Assessment of the Calcium Messenger System in Cultured Mouse Leydig Tumor Cells: Regulation of Human Chorionic Gonadotropin-Induced Expression of the Steroidogenic Acute Regulatory Protein
Endocrinology,
April 1, 1999;
140(4):
1739 - 1751.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
P. R. Manna, M. Tena-Sempere, and I. T. Huhtaniemi
Molecular Mechanisms of Thyroid Hormone-stimulated Steroidogenesis in Mouse Leydig Tumor Cells. INVOLVEMENT OF THE STEROIDOGENIC ACUTE REGULATORY () PROTEIN
J. Biol. Chem.,
February 26, 1999;
274(9):
5909 - 5918.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Lalli, M. H. Melner, D. M. Stocco, and P. Sassone-Corsi
DAX-1 Blocks Steroid Production at Multiple Levels
Endocrinology,
October 1, 1998;
139(10):
4237 - 4243.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
X. Wang, Z. Liu, S. Eimerl, R. Timberg, A. M. Weiss, J. Orly, and D. M. Stocco
Effect of Truncated Forms of the Steroidogenic Acute Regulatory Protein on Intramitochondrial Cholesterol Transfer
Endocrinology,
September 1, 1998;
139(9):
3903 - 3912.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Cherradi, Y. Brandenburger, M. F. Rossier, M. B. Vallotton, D. M. Stocco, and A. M. Capponi
Atrial Natriuretic Peptide Inhibits Calcium-Induced Steroidogenic Acute Regulatory Protein Gene Transcription in Adrenal Glomerulosa Cells
Mol. Endocrinol.,
July 1, 1998;
12(7):
962 - 972.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
F. Arakane, C. B. Kallen, H. Watari, J. A. Foster, N. B. V. Sepuri, D. Pain, S. E. Stayrook, M. Lewis, G. L. Gerton, and J. F. Strauss III
The Mechanism of Action of Steroidogenic Acute Regulatory Protein (StAR). StAR ACTS ON THE OUTSIDE OF MITOCHONDRIA TO STIMULATE STEROIDOGENESIS
J. Biol. Chem.,
June 26, 1998;
273(26):
16339 - 16345.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Brand, N. Cherradi, G. Defaye, A. Chinn, E. M. Chambaz, J.-J. Feige, and S. Bailly
Transforming Growth Factor beta 1 Decreases Cholesterol Supply to Mitochondria via Repression of Steroidogenic Acute Regulatory Protein Expression
J. Biol. Chem.,
March 13, 1998;
273(11):
6410 - 6416.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Ronen-Fuhrmann, R. Timberg, S. R. King, K. H. Hales, D. B. Hales, D. M. Stocco, and J. Orly
Spatio-Temporal Expression Patterns of Steroidogenic Acute Regulatory Protein (StAR) During Follicular Development in the Rat Ovary
Endocrinology,
January 1, 1998;
139(1):
303 - 315.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. D. Petrescu, A. M. Gallegos, Y. Okamura, J. F. Strauss III, and F. Schroeder
Steroidogenic Acute Regulatory Protein Binds Cholesterol and Modulates Mitochondrial Membrane Sterol Domain Dynamics
J. Biol. Chem.,
September 28, 2001;
276(40):
36970 - 36982.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 1997 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|